Edition:
India

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

11.03USD
17 Aug 2018
Change (% chg)

$0.08 (+0.73%)
Prev Close
$10.95
Open
$11.00
Day's High
$11.13
Day's Low
$10.60
Volume
81,258
Avg. Vol
91,765
52-wk High
$15.08
52-wk Low
$5.45

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.23 December 18 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 1 1
(2) OUTPERFORM 2 3 3 3
(3) HOLD 1 0 0 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.60 1.75 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 11.89 15.30 9.50 --
Quarter Ending Dec-18 5 11.96 15.60 9.50 --
Year Ending Dec-18 5 48.62 55.90 43.70 39.17
Year Ending Dec-19 5 50.47 60.00 41.87 35.53
Earnings (per share)
Quarter Ending Sep-18 5 -0.23 -0.15 -0.29 -0.50
Quarter Ending Dec-18 5 -0.24 -0.15 -0.31 -0.39
Year Ending Dec-18 5 -0.81 -0.59 -0.93 -1.36
Year Ending Dec-19 5 -1.16 -0.93 -1.58 -1.27

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 14.06 15.02 0.96 6.84
Quarter Ending Mar-18 7.00 9.55 2.55 36.37
Quarter Ending Dec-17 9.40 56.30 46.90 498.95
Quarter Ending Sep-17 9.03 9.03 0.00 0.05
Quarter Ending Jun-17 8.50 8.94 0.44 5.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 11.89 9.82 9.82 9.77 --
Quarter Ending Dec-18 11.96 9.86 9.86 9.82 --
Year Ending Dec-18 48.62 43.01 43.01 38.50 39.17
Year Ending Dec-19 50.47 47.88 47.88 49.85 35.53

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 2 1 2 1
Quarter Ending Dec-18 2 0 2 0
Year Ending Dec-18 4 1 4 1
Year Ending Dec-19 3 2 3 2
Earnings